Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.

about

Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.Targeting Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) for Cancer Chemoprevention.

P2860

Q38912441-FFFE1124-0ABD-4BEF-90BE-E3A9E2E7B710 Q42551493-342B4D4B-3D7B-480C-B302-10008AE6BADD

P2860

Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.

Item

http://www.wikidata.org/entity/Q39052463

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@en

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@nl

type

Item

label

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@en

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@nl

prefLabel

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@en

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@nl

P1476

Bioactivity screening and mass ...... increase type 1 muscle fibres.

@en

P2093

Astrid R M Hamers

http://www.w3.org/2001/XMLSchema#string

Henri H Heskamp

http://www.w3.org/2001/XMLSchema#string

Leendert A van Ginkel

http://www.w3.org/2001/XMLSchema#string

Marco Blokland

http://www.w3.org/2001/XMLSchema#string

Martien L Essers

http://www.w3.org/2001/XMLSchema#string

Michel W F Nielen

http://www.w3.org/2001/XMLSchema#string

Toine F H Bovee

http://www.w3.org/2001/XMLSchema#string

P2860

Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages

AMPK and PPARdelta agonists are exercise mimetics

Regulation of muscle fiber type and running endurance by PPARdelta

Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene

The mechanisms of action of PPARs

Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors

Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects

The PPARs: from orphan receptors to drug discovery

Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.

STAT6 transcription factor is a facilitator of the nuclear receptor PPARγ-regulated gene expression in macrophages and dendritic cells

P2888

s00216-013-7520-y

P304

705-713

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00216-013-7520-Y

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

406

http://www.w3.org/2001/XMLSchema#string

P50

Sander Kersten

P577

2013-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24287635

http://www.w3.org/2001/XMLSchema#string

Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.

about

P2860

P2860

Bioactivity screening and mass spectrometric confirmation for the detection of PPARδ agonists that increase type 1 muscle fibres.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P50

P577

P698